A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK
Interested in new trials?
Get alerts for new trials in your area by subscribing now
What are Dry Eye Disease clinical trials?
Dry eye disease can range from occasional irritation to a persistent, disruptive problem, and clinical trials reflect that range, testing things like eye drops, devices, and lifestyle-based strategies to improve tear quality and ease discomfort. Researchers also use these studies to better understand what's driving symptoms, since causes can include aging, environmental factors, or autoimmune conditions.
The importance of clinical trials in Dry Eye Disease research
Millions of people deal with dry eye symptoms, often without knowing there's real research behind what actually helps. Dry eye clinical trials matter here because the condition is often tied to autoimmune disorders, so findings in this space can inform care well beyond eye comfort alone.
Who can participate in Dry Eye Disease clinical trials?
Dry eye disease clinical trials typically look for adults who experience ongoing eye discomfort, whether that's occasional dryness or a more constant, disruptive irritation. Some studies focus on dry eye as a standalone issue, while others include people whose symptoms are connected to another condition, like an autoimmune disorder.
Screening usually covers things like age, symptom severity, current eye drops or contact lens use, and results from a basic eye exam. Depending on the study, people without dry eye symptoms may also be enrolled as a comparison group.
What to expect when joining a Dry Eye Disease clinical trial?
Most trials begin with an eye exam and a few simple tests to measure tear production and the health of the eye's surface, which helps confirm eligibility. From there, the research team explains the study through informed consent, covering what's being tested and what risks or benefits to expect.
Depending on the trial, participants might use eye drops, try a specific device, or follow a set eye-care routine, with follow-up visits scheduled to see how symptoms and tear quality change over time.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Types of Dry Eye Disease clinical trials
Dry eye disease affects millions of people to varying degrees, a dry eye research studies cover a range of approaches, since symptoms can come from different underlying issues, from how much moisture the eyes produce, to how quickly that moisture evaporates. Because of that, most trials fall into a few general categories.
Eye drop and medication trials
Eye drop and medication trials test topical options, like cyclosporine-based drops or advanced artificial tear formulations, to see how well they improve tear quality and ease irritation. Participants typically include adults with diagnosed dry eye disease, and studies often track tear production and symptom scores over several weeks.
Device-based trials
These trials look at physical devices, such as intense pulsed light devices or punctal plugs, that target the glands and tear ducts involved in keeping the eyes lubricated. Participants often include people whose dry eye is linked to meibomian gland dysfunction, and research usually measures changes in tear film stability and comfort.
Underlying cause and combination trials
These trials study dry eye that develops alongside another condition, like autoimmune disease or long-term contact lens wear, sometimes combining a drop-based and device-based approach in the same study. Participants usually include people managing a related health condition, and research looks at how addressing the underlying cause affects eye comfort overall.
How long do dry eye disease clinical trials typically last?
How long a dry eye disease clinical trial lasts depends a lot on what's being tested. Eye drop and medication trials often run around 8 to 12 weeks, since that's typically enough time to see meaningful changes in tear quality and symptoms. Device-based trials, like those testing intense pulsed light devices, can sometimes be shorter, with sessions spread out over just a few weeks. Studies looking at dry eye tied to another condition, like an autoimmune disorder, may run longer, since researchers are also tracking how that underlying condition is progressing.
How to enroll in a clinical trial for Dry Eye Disease
Enrolling in a Dry Eye Disease clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials focused on dry eye disease and related eye health research. This first step simplifies the process of finding studies relevant to your symptoms, whether that's occasional irritation or ongoing discomfort.
- Select Your Preferred Location: To find dry eye clinical trials near you, including those affiliated with eye care or ophthalmology centers, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the "Learn More" button. This will provide you with comprehensive details about the trial, including objectives, procedures such as tear film tests or eye exams, and eligibility criteria.
- Complete the Health Profile: After clicking on the "Get started" button you will be taken to our efficient 5-step application process to provide important health information, including your eye health history and the symptoms you've been experiencing, like dryness, burning, or sensitivity to light. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.